全球首款新冠口服药莫努匹韦在天津怎么购买?
Monupivir was launched in the UK in 2021 and is the world's first oral anti-coronavirus drug. The drug was jointly developed by Merck and Ridgeback Biotechnology. It can cause the virus to produce wrong mutations, interfere with virus replication, achieve antiviral effects, and is active against a variety of RNA viruses, including the new coronavirus.
So, how to buy Monupivir, the world’s first oral COVID-19 drug, in Tianjin?
Currently, Monupivir is not available in China. Patients in Tianjin, including other parts of the country, cannot buy this drug in local hospital pharmacies. They need to go abroad to purchase it, but the cost is higher. It is recommended that patients obtain the overseas version of Monupivir through Medical Companion Travel, which is directly mailed from the pharmaceutical factory. It is cost-effective, affordable and guaranteed to be genuine. Medical Companion Travel has cooperated with many domestic patients and is deeply trusted. For details on how much it costs to purchase the overseas version of Monupivir and the drug purchase process, please consult the Medical Companion Travel Service staff.
Oral medicines for COVID-19 are therapeutic drugs and should only be used if you are infected with COVID-19. The COVID-19 epidemic has swept the world. Monupivir is the first oral antiviral drug to treat COVID-19. It is a small molecule RNA polymerase inhibitor. The recommended dose of this medicine is 800 mg (four 200 mg capsules) taken orally every 12 hours for 5 days. Monupivir is the world's first oral antiviral drug approved for the treatment of mild to moderate COVID-19 infection in adults. It should be noted that this drug is not suitable for severe patients.
Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.
Recommended related articles:
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)